Breast cancer and histocompatibility antigens
Subirá ML, Crisci CD, Zornoza G, Sanz ML, Voltas J, Hernández JL, Oehling A.
Department of Allergology and Clinic Immunology. Clínica Universitaria de Navarra. Pamplona. Spain.
Revista: Allergologia et Immunopathologia
Fecha: 01/12/1979Área de Patología Mamaria Alergología e Inmunología Clínica
HLA antigens and haplotypes were studied in 50 women with infiltrating ductal carcinoma of the breast, from the Basque provinces and Navarra, and in a comtrol group consisted of 166 healthy persons from the same geographical area. A greater incidence of HLA-B7 and B26 was observed in the breast cancer group if compared with the frequency of occurrence of these antigens in the Spanish population. However, when compared with Navarra-Basque population, no significant differences were observed.
The study of the haplotype frequencies in breast cancer showed a greater incidence of the A9, B27 and A10, B14 haplotypes than in the normal population. However, the significance of D values disappeared after making the necessary correction for the number of antigens tested. The major histocompatibility system has a variety of functions which have not yet been documented but that might predispose to disease.
It is certainly probable that there will be multiple mechanisms underlying HLA and cancer associations, however so far none of the data available suggest the presence of an immune response gene linked with breast cancer.
CITA DEL ARTÍCULO Allergol Immunopathol (Madr). 1979 Nov-Dec;7(6):411-6
tal vezLE INTERESE
La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.
Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.
Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.